Table 4 Prevalence of concomitant antibodies to viral hepatitis, HIV and HSV-2, Puerto Rico, 2005-2008.

--

27.1 (13.9 - 46.0)^a

61.2 (34.5 - 82.5)

2.2 (0.5 - 8.6)

55.4 (30.9 - 77.6)^b

--

2.7 (2.0 - 3.8)

40.9 (37.8 - 44.1)

0.8 (0.4 - 1.6)

21.7 (18.5 - 25.3)

17.4 (8.5 - 32.3)^a

--

71.5 (56.7 - 82.7)^a

--

39.9 (27.5 - 53.7)^b

1.7 (1.0 - 2.8)

--

40.3 (37.1 - 43.6)

--

21.7 (18.6 - 25.3)

3.3 (1.8 - 6.1)

5.7 (3.9 - 8.3)^a

--

1.4 (0.6 - 3.0)

29.4 (24.8 - 34.5)^a

1.4 (0.6 - 3.2)

1.6 (1.0 - 2.7)

--

0.5 (0.1 - 1.7)

17.6 (14.2 - 21.5)

5.2 (1.0 - 23.0)

--

66.2 (29.5 - 90.1)

--

89.3 (57.0 - 98.1)^a

2.2 (1.3 - 3.5)

--

41.1 (37.9 - 44.4)

--

21.9 (18.7 - 25.4)

5.1 (2.5 - 10.1)^b

6.2 (3.9 - 9.8)^b

53.7 (46.5 - 60.8)^a

3.0 (1.2 - 6.9)^a

--

1.2 (0.6 - 2.3)

2.7 (1.8 - 3.9)

36.9 (33.9 - 40.0)

0.1 (0.02 - 0.4)

--